Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1798609A reveals a novel copper catalyst system enabling high-yield, low-temperature synthesis of optically active cyclopropane compounds for pyrethroid production.
Patent CN103665038A details a room-temperature synthesis of (RP)-menthylphenylphosphine oxide, offering a cost-effective route for high-purity chiral ligand precursors.
Patent CN102382138B details a robust two-step synthesis for chiral phosphoramides. Discover cost-effective manufacturing routes for asymmetric catalysis intermediates.
Patent CN113135955B discloses a scalable route for C2 symmetric Trost ligands, offering cost reduction in asymmetric catalysis manufacturing and reliable supply.
Patent CN1098856C discloses novel chiral amidophosphine trivalent phosphonate ligands enabling high-efficiency asymmetric hydrogenation for pharmaceutical and fine chemical manufacturing.
Novel 5,5'-linked biphenyl ligand patent CN103524557B offers high enantioselectivity for API manufacturing and supply chain reliability for global buyers seeking partners.
Patent CN112876401A discloses a mild, one-step iridium-catalyzed synthesis of chiral 3-allylindoles with high enantioselectivity, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN111646958B reveals a novel organocatalytic route for carfilzomib intermediates, offering high purity and cost-effective manufacturing solutions for global supply chains.
Discover a novel high-yield synthesis for S-pantoprazole sodium using sodium bismuthate. Enhanced optical purity and cost-effective manufacturing for global supply chains.
Patent CN110467537B reveals a streamlined 6-step synthesis for L-p-hydroxyphenylglycine, offering significant cost reduction and yield improvements for antibiotic manufacturers.
Novel synthesis of Sacubitril intermediate via Cu-catalyzed coupling. Reduces cost, improves yield, scalable process for heart failure drug manufacturing.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Novel chiral ligand L1 enables high purity esomeprazole production with improved yield and supply chain reliability for pharmaceutical manufacturers globally.
Patent CN101260085A reveals a high-efficiency palladium-catalyzed asymmetric hydrogenation route for chiral gamma-sultams, offering superior enantioselectivity and scalable manufacturing advantages.
Advanced phase-transfer catalysis process for high-purity antiviral intermediates. Reduces steps and improves optical purity compared to enzymatic resolution methods.
Novel aqueous catalytic method reduces cost and improves purity for luliconazole intermediate manufacturing ensuring supply chain stability.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.
Patent CN103755554A details a novel cobalt-catalyzed Kumada coupling route for high-purity (S)-fenoprofen, offering significant cost reduction in NSAID manufacturing.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.